United States Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-09-10
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-united-states-callable
United States Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-09-10: 10Y at 5.64%, fitted curve 3M–40Y (4.49%–6.18%), 660 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 3M | 4.49% | — |
| 6M | 4.54% | 4.69% |
| 9M | 4.60% | 4.88% |
| 12M | 4.68% | 4.88% |
| 18M | 4.81% | 5.15% |
| 2Y | 4.90% | 5.23% |
| 3Y | 5.03% | 5.41% |
| 4Y | 5.16% | 5.67% |
| 5Y | 5.28% | 5.91% |
| 6Y | 5.39% | 6.09% |
| 7Y | 5.47% | 6.20% |
| 8Y | 5.54% | 6.23% |
| 9Y | 5.59% | 6.24% |
| 10Y | 5.64% | 6.33% |
| 15Y | 5.97% | 7.18% |
| 20Y | 6.10% | 7.03% |
| 25Y | 6.15% | 6.71% |
| 30Y | 6.17% | 6.55% |
| 40Y | 6.18% | 6.41% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.90% and the 10-year 5.64%, a 10Y−2Y spread of +74 bp — positively sloped — as of 2026-09-10. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-09-10 | 1m ago2026-08-11 | 2m ago2026-07-13 | 3m ago2026-06-12 | 4m ago2026-05-13 | 5m ago2026-04-13 | 6m ago2026-03-13 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.90% | 4.69% | 4.68% | 4.57% | 4.49% | 4.38% | 4.23% |
| 10Y | 5.64% | 5.48% | 5.31% | 5.34% | 5.28% | 5.16% | 5.10% |
| 10Y − 2Y | +74 bp | +79 bp | +63 bp | +77 bp | +78 bp | +78 bp | +87 bp |
Yields by rating group
The same curve split by credit quality: 719 rated bonds across 3 rating bands, all maturities pooled. Median yield by band: AAA to AA- 5.41%, A+ to BBB- 5.55%, Speculative 6.32%.
Bonds in this curve
A selection of 30 of the 722 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Abbvie INC | 4.17% | 2026-11-21 | 2.95% | US00287YBV02 |
| Abbott Laboratories | 4.29% | 2026-11-30 | 3.75% | US002824BF69 |
| Stryker Corp | 4.78% | 2027-02-10 | 4.55% | US863667BJ94 |
| HCA INC | 4.55% | 2027-02-15 | 4.50% | US404119BU21 |
| ELI Lilly & CO | 4.41% | 2027-05-15 | 3.10% | US532457BP26 |
| Becton Dickinson & CO | 4.96% | 2027-06-06 | 3.70% | US075887BW84 |
| CVS Health Corp | 4.68% | 2027-08-21 | 1.30% | US126650DM98 |
| Johnson & Johnson | 4.31% | 2027-09-01 | 0.95% | US478160CP78 |
| Illumina INC | 5.06% | 2027-12-13 | 5.75% | US452327AP42 |
| Cencora INC | 4.96% | 2027-12-15 | 3.45% | US03073EAP07 |
| Edwards Lifesciences Corp | 5.06% | 2028-06-15 | 4.30% | US28176EAD04 |
| Mckesson Corp | 4.92% | 2028-07-15 | 4.90% | US581557BT10 |
| Abbvie INC | 5.06% | 2029-03-15 | 4.80% | US00287YDS54 |
| ELI Lilly & CO | 4.94% | 2029-03-15 | 3.38% | US532457BV93 |
| Abbvie INC | 5.01% | 2030-03-15 | 4.88% | US00287YDZ97 |
| Abbvie INC | 5.12% | 2030-03-15 | 4.65% | US00287YEM75 |
| Agilent Technologies INC | 5.21% | 2031-03-12 | 2.30% | US00846UAN19 |
| Abbott Laboratories | 5.05% | 2031-03-15 | 4.00% | US002824BS80 |
| BIO-RAD Laboratories INC | 5.58% | 2032-03-15 | 3.70% | US090572AQ17 |
| Bristol-Myers Squibb CO | 5.25% | 2032-03-15 | 2.95% | US110122DU92 |
| Abbott Laboratories | 5.25% | 2033-03-15 | 4.30% | US002824BT63 |
| Abbvie INC | 5.30% | 2033-03-15 | 4.40% | US00287YEF25 |
| Abbvie INC | 5.35% | 2034-03-15 | 5.05% | US00287YDU01 |
| Abbvie INC | 5.46% | 2035-03-15 | 5.20% | US00287YEA38 |
| Abbott Laboratories | 5.48% | 2036-03-15 | 4.65% | US002824BU37 |
| Pfizer INC | 5.86% | 2039-03-15 | 7.20% | US717081CY74 |
| Abbvie INC | 5.97% | 2044-03-15 | 5.35% | US00287YDV83 |
| ELI Lilly & CO | 6.01% | 2049-03-15 | 3.95% | US532457BT48 |
| Abbvie INC | 6.10% | 2054-03-15 | 5.40% | US00287YDW66 |
| Merck & CO INC | 6.13% | 2061-12-10 | 2.90% | US58933YBG98 |